Drug Trial Radar · NCT06411912
A Study of NIDO-361 in Patients With SBMA
Last checked: Nov 19, 2026Latest source record: Mar 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Mar 1, 2024
Primary completion
Oct 22, 2025
Study completion Oct 22, 2025
Sponsor
- Lead sponsor
- Nido Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 13, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, and efficacy of NIDO-361 in adult patients with Spinal and Bulbar Muscular Atrophy (SBMA).
Conditions
- Spinal and Bulbar Muscular Atrophy
- Kennedy's Disease
Interventions
NIDO-361Drug
Tablets containing 100mg of NIDO-361 for oral administration.
PlaceboDrug
Placebo oral tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Analysis of Thigh and Total Lean Muscle Volume (LMV) [A+B+C]Time frame: Baseline, Day 180, Days 360-374 (Last Visit)
- Number of Participants With Adverse Events (AEs) or Serious Adverse Events (SAEs)Time frame: Through study completion, an average of 1 year
- Number of Participants Discontinuing Study Drug and Number of Participants' DeathsTime frame: Through study completion, an average of 1 year
- Total Number of Mild, Moderate, and Severe Adverse Events (AEs) Across All ParticipantsTime frame: Through study completion, an average of 1 year
Locations
5 sites in 4 countries. Site status is shown where the registry gives one.
Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center
Copenhagen, Denmark
IRCCS Istituto Neurologico Carlo Besta
Milan, Italy
Azienda Ospedale Università di Padova
Padova, Italy
Kyungpook National University Chilgok Hospital
Daegu, South Korea
University of College London Hospital (UCLH)
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.